Castle Creek Pharmaceutical Holdings to Acquire Fibrocell

    NEXT STORY
    SpringWorks Therapeutics Announces Pricing Of Initial Public Offering
    PREV STORY
    Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Infectious Disease Diagnostics Market Worth $12.88 Billion by 2025- Exclusive Report by Meticulous Research®

    author_avatar
    NASDAQ Market News

    Helsinn Group signs Exclusive Agreement with Purdue Pharma (Canada) for the Distribution and Licensing Rights of Aloxi® (palonosetron hydrochloride) in Canada

    Helsinn Group signs Exclusive Agreement with Purdue Pharma (Canada) for the Distribution and Licensing ...

    author_avatar
    NASDAQ Market News

    Roche enters into definitive merger agreement to acquire Spark Therapeutics

    author_avatar
    NASDAQ Market News